Future of the Global Metagenomics In Healthcare Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Metagenomics In Healthcare Market Size Growth Forecast: What to Expect by 2025?
The market size of metagenomics in healthcare has seen a steep growth recently. It is set to expand from $2.07 billion in 2024 to $2.44 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. Factors such as the increasing utilization of bioinformatics tools for the analysis of intricate metagenomic data, a growing demand for speedy and precise pathogen detection methods, and the escalating use of metagenomics in identifying drugs and biomarkers contributed to the growth during the historic period.

How Will the Metagenomics In Healthcare Market Size Evolve and Grow by 2029?
It's projected that the healthcare metagenomics market will experience substantial growth in the near future, expanding to a value of $4.66 billion by 2029 with a compound annual growth rate (CAGR) of 17.6%. This expansion during the predicted period can be associated with an increased occurrence of infectious diseases, a growing need for precision medicine, intensified attention paid towards antimicrobial resistance surveillance through metagenomics, the widening use of metagenomics for oncological research and diagnosis, and heightened knowledge of microbiome-focused therapies and interventions. Key trends for the forecast period encapsulate advancements in sequencing platform technology, breakthroughs in bioinformatics pipeline, advancements in single-cell metagenomics, R&D strides in microbiome treatments, and the incorporation of artificial intelligence in data interpretation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report

What Drivers Are Propelling the Growth of Metagenomics In Healthcare Market Forward?
The surge in infectious diseases is projected to drive the expansion of the metagenomics in healthcare market. Infectious diseases are ailments caused by harmful organisms such as bacteria, viruses, fungi, or parasites that have the potential to spread from one individual to another, either directly or indirectly. The upsurge in these diseases is mainly due to higher levels of travel, resulting in pathogens quickly crossing borders. Metagenomics plays an essential role in healthcare by enabling prompt and accurate detection of pathogens, crucial for managing disease outbreaks. It mitigates diagnostic ambiguity by assessing intricate microbial communities, thereby refining patient results and supporting directed treatments. For example, the UK Health Security Agency, a government body, reported that tuberculosis cases in England, primarily affect the lungs climbed to 4,850 in 2023 from 4,380 in 2022, a jump of 10.7%. As such, the escalating instances of infectious diseases are propelling the growth of the metagenomics in healthcare market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp

Which Emerging Trends Are Transforming the Metagenomics In Healthcare Market in 2025?
Leading firms in the metagenomics in healthcare sector are concentrating on the creation of novel solutions, such as microbial community profiling, in order to improve disease diagnostics, personalize therapies, and further progress in precision medicine. Microbial community profiling involves a thorough examination and profiling of varied microbial groups within a particular environment or specimen, by utilizing sequencing and bioinformatics tools to establish their composition, diversity, and functional roles. For example, in August 2024, MGI Tech Co. Ltd., a biotech company based in China, introduced a Human Microbiome Metagenomics Sequencing Package to boost microbial investigation and healthcare applications. This package provides a fully automated microbial community profiling process, making it easier to effectively examine human microbiome diversity, functionality, and disease associations using validated, high-capacity platforms. It cuts down on manual work, increases reproducibility, and lowers costs, thereby making high-volume and clinical microbiome investigation more accessible. The benefits for researchers include quick and accurate identification of microbes, scalable throughput, facilitating the discovery of biomarkers, and promoting translational health research.

What Are the Key Segments in the Metagenomics In Healthcare Market?
The metagenomics in healthcare market covered in this report is segmented as

1) By Types: Sample Extraction Kits, Metagenomics Kits
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray
3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing
4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery
5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies

Subsegments:
1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits
2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28267&type=smp

Who Are the Key Players Shaping the Metagenomics In Healthcare Market's Competitive Landscape?
Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.

What Geographic Markets Are Powering Growth in the Metagenomics In Healthcare Market?
North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28267

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.